Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PMS Study of MicardisPlus Tablet.

Trial Profile

PMS Study of MicardisPlus Tablet.

Phase of Trial: Phase IV

Latest Information Update: 16 Jul 2014

At a glance

  • Drugs Telmisartan/hydrochlorothiazide (Primary)
  • Indications Essential hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms PMS
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 23 Oct 2009 Planned number of patients changed from 6764 to 6901 as reported by ClinicalTrials.gov.
    • 28 Jan 2009 Actual initiation date (Sep 2003) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top